These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36368417)
1. A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis. Zeng YS; Peng J; Gao XF; Tian D; Zhan W; Liu J; Hu XJ; Huang S; Tian ST; Qiu L; Liang AL; Wang FY; Dong RH; Guang B; Yang T Eur J Pharmacol; 2022 Dec; 937():175381. PubMed ID: 36368417 [TBL] [Abstract][Full Text] [Related]
2. A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis. Zhang C; Luo Y; He Q; Liu S; He A; Yan J Clin Sci (Lond); 2019 Apr; 133(8):919-932. PubMed ID: 30944150 [TBL] [Abstract][Full Text] [Related]
3. A natural chalcone cardamonin inhibits necroptosis and ameliorates dextran sulfate sodium (DSS)-induced colitis by targeting RIPK1/3 kinases. Shen X; Chen H; Wen T; Liu L; Yang Y; Xie F; Wang L Eur J Pharmacol; 2023 Sep; 954():175840. PubMed ID: 37302524 [TBL] [Abstract][Full Text] [Related]
4. Hesperetin ameliorates DSS-induced colitis by maintaining the epithelial barrier via blocking RIPK3/MLKL necroptosis signaling. Zhang J; Lei H; Hu X; Dong W Eur J Pharmacol; 2020 Apr; 873():172992. PubMed ID: 32035144 [TBL] [Abstract][Full Text] [Related]
5. Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice. Guo Y; Wu X; Wu Q; Lu Y; Shi J; Chen X Toxicol Appl Pharmacol; 2018 Apr; 344():35-45. PubMed ID: 29496522 [TBL] [Abstract][Full Text] [Related]
6. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019 [TBL] [Abstract][Full Text] [Related]
7. ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis. Bao J; Ye B; Ren Y Genet Res (Camb); 2022; 2022():9313559. PubMed ID: 36034412 [TBL] [Abstract][Full Text] [Related]
8. HuanglianGanjiang Tang alleviates DSS-induced colitis in mice by inhibiting necroptosis through vitamin D receptor. Xiong X; Cheng Z; Zhou Y; Wu F; Xie L; Lawless L; Dong R; Zhao Y; Yu L; Chen G J Ethnopharmacol; 2022 Nov; 298():115655. PubMed ID: 35988837 [TBL] [Abstract][Full Text] [Related]
9. The natural compound celastrol inhibits necroptosis and alleviates ulcerative colitis in mice. Jia Z; Xu C; Shen J; Xia T; Yang J; He Y Int Immunopharmacol; 2015 Dec; 29(2):552-559. PubMed ID: 26454701 [TBL] [Abstract][Full Text] [Related]
10. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688 [TBL] [Abstract][Full Text] [Related]
11. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway. Dai Y; Lu Q; Li P; Zhu J; Jiang J; Zhao T; Hu Y; Ding K; Zhao M J Ethnopharmacol; 2023 Jan; 300():115690. PubMed ID: 36075274 [TBL] [Abstract][Full Text] [Related]
12. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation. Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298 [TBL] [Abstract][Full Text] [Related]
13. Neferine, a Bisbenzylisoquinoline Alkaloid, Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis. Wu X; Guo Y; Min X; Pei L; Chen X Am J Chin Med; 2018; 46(6):1263-1279. PubMed ID: 30149754 [TBL] [Abstract][Full Text] [Related]
14. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation. Wong J; Garcia-Carbonell R; Zelic M; Ho SB; Boland BS; Yao SJ; Desai SA; Das S; Planell N; Harris PA; Font-Burgada J; Taniguchi K; Bertin J; Salas A; Pasparakis M; Gough PJ; Kelliher M; Karin M; Guma M Cell Mol Gastroenterol Hepatol; 2020; 9(2):295-312. PubMed ID: 31606566 [TBL] [Abstract][Full Text] [Related]
15. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity. Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543 [TBL] [Abstract][Full Text] [Related]
16. Rho kinase Blockade Ameliorates DSS-Induced Ulcerative Colitis in Mice Through Dual Inhibition of the NF-κB and IL-6/STAT3 Pathways. Wang Y; Duan X; Liu X; Liu Y; Fan H; Xu M; Chen Q; Tang Q Inflammation; 2020 Jun; 43(3):857-867. PubMed ID: 31916050 [TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311 [TBL] [Abstract][Full Text] [Related]
18. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota. He X; Liu J; Long G; Xia XH; Liu M Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of HtrA2 alleviated dextran sulfate sodium (DSS)-induced colitis by preventing necroptosis of intestinal epithelial cells. Zhang C; He A; Liu S; He Q; Luo Y; He Z; Chen Y; Tao A; Yan J Cell Death Dis; 2019 Apr; 10(5):344. PubMed ID: 31019191 [TBL] [Abstract][Full Text] [Related]
20. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3. Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]